The World Post-STICH: Is This A "Game Changer?" A Non-Invasive Cardiologist's Perspective-Revascularization Is The Treatment of Choice Only In Patients Who Fail Medical Therapy

Progress in Cardiovascular Diseases

Volumn 55, Issue 5, 2013, Pages 466-469

  Elamm, Chantal ^a   Fang, James C ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery bypass grafting; Heart failure; Ischemic cardiomyopathy; STICH trial; Viability

Indexed keywords

CARVEDILOL;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG TREATMENT FAILURE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART VOLUME; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC CARDIOMYOPATHY; MEDICAL DECISION MAKING; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVASCULARIZATION;

AGED; ATTITUDE OF HEALTH PERSONNEL; CARDIOLOGY; CARDIOVASCULAR AGENTS; CAUSE OF DEATH; CORONARY ARTERY BYPASS; CORONARY STENOSIS; DECISION MAKING; EVALUATION STUDIES AS TOPIC; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PATIENT SELECTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84875275822     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2012.10.014     Document Type: Article

References (20)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012, 125(1):e2-e220.
2. O'Connor C.M., Velazquez E.J., Gardner L.H., et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol 2002, 90(2):101-107.
3. Allman K.C., Shaw L.J., Hachamovitch R., et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002, 39(7):1151-1158.
4. Eagle K.A., Guyton R.A., Davidoff R., et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004, 110(14):e340-e437.
5. Alderman E.L., Fisher L.D., Litwin P., et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983, 68(4):785-795.
6. Hillis L.D., Smith P.K., Anderson J.L., et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 124(23):2610-2642.
7. Velazquez E.J., Lee K.L., Deja M.A., et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011, 364(17):1607-1616.
8. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33(14):1787-1847.
9. Jessup M., Brozena S. Heart failure. N Engl J Med 2003, 348(20):2007-2018.
10. Cleland J.G., Pennell D.J., Ray S.G., et al. Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet 2003, 362(9377):14-21.
11. Mark D.K.J., Velazquez E.J., et al. Quality of life outcomes in the surgical treatment of ischemic heart failure. Paper presented at: Heart Failure Society of America 2011 Scientific Meeting, Boston, MA 2011.
12. Bonow R.O., Maurer G., Lee K.L., et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011, 364(17):1617-1625.
13. Packer M., O'Connor C.M., Ghali J.K., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 1996, 335(15):1107-1114.
14. Data presented at the 49th Annual Scientific Session of the ACC A, CA, March, 2000.
15. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004, 351(24):2481-2488.
16. Jones R.H., Velazquez E.J., Michler R.E., et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 2009, 360(17):1705-1717.
17. Jones R.H., White H., Velazquez E.J., et al. STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. J Am Coll Cardiol 2010, 56(6):490-498.
18. Zembala M., Michler R.E., Rynkiewicz A., et al. Clinical characteristics of patients undergoing surgical ventricular reconstruction by choice and by randomization. J Am Coll Cardiol 2010, 56(6):499-507.
19. Cleland J.G., Calvert M., Freemantle N., et al. The Heart Failure Revascularisation Trial (HEART). Eur J Heart Fail 2011, 13(2):227-233.
20. Beanlands R.S., Nichol G., Huszti E., et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007, 50(20):2002-2012.